Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 4/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | GNG2 | P59768 | 1/20 | 0.30 |
| ▸ | GNB1 | P62873 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24011828 | 0.94 | DPP4 (0.46) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24011832 | 0.94 | ANPEP (0.46) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24011908 | 0.91 | DPP4 (0.42) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24012251 | 0.90 | DPP4 (0.49) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL20412268 | 0.87 | ANPEP (0.50) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL25868389 | 0.85 | ANPEP (0.43) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24011907 | 0.84 | DPP4 (0.45) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24012109 | 0.84 | ANPEP (0.45) | DPP4NR1H2NR1H3ANPEPLMNA | |
| SCHEMBL11954355 | 0.84 | ANPEP (0.47) | DPP4NR1H2NR1H3ANPEPADRB2 | |
| SCHEMBL24011807 | 0.83 | ANPEP (0.43) | DPP4NR1H2NR1H3ANPEPADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | Konica Minolta, Inc. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | IGF1R, IK, BMI1 | DPP4 4366/4885NR1H2 1914/4885NR1H3 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.